US Bancorp
ZVRA icon

US Bancorp’s Zevra Therapeutics ZVRA Stock Holding History

US Bancorp’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.64K Buy
1,034
+34
+3% +$306 ﹤0.01% 3375
2025
Q4 		$8.96K Hold
1,000
– – ﹤0.01% 3374
2025
Q3 		$9.51K Sell
1,000
-55
-5% -$552 ﹤0.01% 3330
2025
Q2 		$9.29K Buy
1,055
+42
+4% +$341 ﹤0.01% 3453
2025
Q1 		$7.59K Buy
1,013
+13
+1% +$103 ﹤0.01% 3528
2024
Q4 		$8.34K Hold
1,000
– – ﹤0.01% 3486
2024
Q3 		$6.94K Hold
1,000
– – ﹤0.01% 3474
2024
Q2 		$4.9K Hold
1,000
– – ﹤0.01% 3520
2024
Q1 		$5.8K Hold
1,000
– – ﹤0.01% 3490
2023
Q4 		$6.55K Buy
+1,000
New +$4.68K ﹤0.01% 3450

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return